Newsroom

Sorted by: Latest

-

Global Payments Named Commerce Technology Provider for University of Memphis Tigers

ATLANTA--(BUSINESS WIRE)--Global Payments Inc. (NYSE: GPN) today announced it has been selected as the Commerce Technology Provider for the University of Memphis Tigers....
-

Intermatic Acquires Sunrise Technologies, Strengthens Infrastructure Lighting Controls Portfolio

LIBERTYVILLE, Ill.--(BUSINESS WIRE)--Intermatic acquires Sunrise Technologies, strengthening its infrastructure lighting controls portfolio and laying a foundation for growth....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Rising Dividend Achievers UCITS ETF 04.11.2026 EDVY.LN IE000CPG9HG3   50,002.00 EUR   1,162,995.70   23.259  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Nuclear Power UCITS ETF 04.11.2026 RCTR.LN IE000J5PESP7 3,300,002.00 USD  53,134,467.68   16.101  ...
-

Soracom Named a Leader in Omdia Market Radar: IoT MVNOs, 2026

SEATTLE--(BUSINESS WIRE)--Soracom, Inc. (TSE: 147A), a cloud-native IoT platform providing connectivity, cloud integration, and AI services for the Internet of Things, today announced that Omdia has named Soracom a Leader in the 2026 Omdia Market Radar: IoT MVNOs report. In Omdia’s 2025 Market Radar, Soracom was positioned as a Challenger. In the 2026 edition, Omdia observes the company had "an impressive 2025, catapulting it into the leaders' quadrant." Omdia narrowed a field of more than 25 I...
-

Kairos Pharma Recognized by Biotech Breakthrough Awards in Oncology

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company targeting drug resistance in cancer, announces that it has been named a winner of the 2026 Biotech Breakthrough Awards in the category of Cancer Immunology Solution of the Year for its work with ENV-105 targeting cancer drug resistance in metastatic prostate cancer and non-small cell lung cancer. Kairos Pharma was recognized for its differentiated approach to targeting the biologi...
-

MedTech Innovator Announces the 2026 Mid-Stage Grand Prize and Execution Award Winners

LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Vektor Medical won MedTech Innovator’s $200,000 2026 Mid-Stage Grand Prize and Lenneuro won the $25,000 Execution Award in San Diego....
-

Popular, Inc. Declares Dividend on Preferred Stock and Announces Distribution on Trust Preferred Securities

SAN JUAN, Puerto Rico--(BUSINESS WIRE)--Popular, Inc. (NASDAQ: BPOP) announced today that it has declared the following monthly cash dividend on its outstanding shares of Non-Cumulative Monthly Income Preferred Stock: a monthly cash dividend of $0.132813 per share of 6.375% Non-Cumulative Monthly Income Preferred Stock, 2003 Series A, payable on November 30, 2026 to holders of record as of November 15, 2026. The Corporation also announced the following monthly distribution on its outstanding Tr...
-

Paige Riddle of LSP Products Elected President of Plumbing Manufacturers International’s 2027 Board of Directors

NEW ORLEANS--(BUSINESS WIRE)--Paige Riddle of LSP Products Elected President of Plumbing Manufacturers International’s 2027 Board of Directors...
-

PSQ Holdings Announces Third Quarter 2026 Financial Results Release Date & Conference Call

BOZEMAN, Mont.--(BUSINESS WIRE)--PSQ Holdings, Inc. (NYSE: PSQH) (the "Company") today announced it will host a teleconference and webcast to discuss its third quarter 2026 results beginning at 9:00 a.m. EST on Friday, November 6, 2026. The Company will issue a news release on November 6, 2026, before the U.S. stock market opens, containing third quarter 2026 results. The conference call can be accessed live through a link on the PSQ Holdings Investor Relations website at investors.publicsquare...